Ibrutinib in Chronic GVHD Could Greatly Impact Patient Care

Ibrutinib in Chronic GVHD Could Greatly Impact Patient Care

User Photo
ASHReport

4 years
677 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
David Miklos, MD, PhD of Stanford University Medical Center, discusses ibrutinib in Chronic Graft-versus-Host Disease at the 58th ASH Annual Meeting in San Diego, CA.
Up Next Autoplay
>